GCOR Genencor International, (MM)

Genencor Makes Forbes 200 Best Small Companies List Elite Ranking Based on Financial Performance PALO ALTO, Calif., Oct. 18 /PRNewswire-FirstCall/ -- Genencor International, Inc. (NASDAQ:GCOR) announced that it was listed among the 200 Best Small Companies List compiled by Forbes magazine. This is the first time Genencor was included on the list, which considers the financial performance of companies with sales in the $5 million to $750 million range. "Every year we're more particular about membership in this elite list," Forbes said. "To qualify candidates have to show a consistent pattern of positive growth during a five-year period as well as over the last 12 months." "Among the many honors we have received this year, we are particularly pleased to be recognized for our financial performance and to be among this list of innovative companies," said Genencor's chairman and CEO Jean-Jacques Bienaime. About Genencor Genencor International is a diversified biotechnology company that develops and delivers innovative products and services into the health care, agri-processing, industrial and consumer markets. Using an integrated set of technology platforms, Genencor's products deliver innovative and sustainable solutions to improve the quality of life. Genencor traces its history to 1982 and has grown to become a leading biotechnology company, with over $380 million in year 2003 annual revenues. Genencor has principal offices in Palo Alto, California; Rochester, New York; and Leiden, the Netherlands. DATASOURCE: Genencor International, Inc. CONTACT: media, Valerie Tucker, +1-650-846-7571, or investors, Thomas Rathjen, +1-650-846-5817, both of Genencor International, Inc. Web site: http://www.genencor.com/

Copyright